Wound :: Rapid healing with novel wound dressings

Bayer plans to enter the market for wound-healing products. Bayer Innovation GmbH ? a subsidiary of Bayer AG ? has developed a leading-edge technology for the manufacture of bioresorbable wound dressings on the basis of silica gel fibers. A ceremony was held on May 4 in Leverkusen to mark the inauguration of a pilot plant which will manufacture the wound dressing in sufficient quantities to enable clinical trials to be carried out.

Cancer :: Significant developments in understanding and targeting cancers

Data demonstrating genetic differences in individuals? susceptibility to certain cancers as well as differences in how people respond to specific cancer treatments will take center stage when more than 17,000 scientists from around the world gather at the Los Angeles Convention Center April 14-18 for the 2007 Annual Meeting of the American Association for Cancer Research (AACR). Key data presented at the meeting will also include findings related to the safety and effectiveness of several new, high-profile cancer therapies and vaccines.

Breast Cancer :: M. D. Anderson joins the US-Middle East Partnership for Breast Cancer Awareness, Research

The University of Texas M. D. Anderson Cancer Center has joined the U.S.-Middle East Partnership for Breast Cancer Awareness and Research, a collaboration designed to increase early breast cancer detection and reduce related deaths in the region through improved awareness, increased clinical resources and world-class research.